Skip Navigation

JNCI Journal of the National Cancer Institute 2006 98(11):724-725; doi:10.1093/jnci/djj226
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Patz, E. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patz, E. F., Jr.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press.

EDITORIAL

Lung Cancer Screening, Overdiagnosis Bias, and Reevaluation of the Mayo Lung Project

Edward F. Patz, Jr.

Correspondence to: Edward F. Patz, Jr., MD, Departments of Radiology and of Pharmacology and Cancer Biology, Duke University Medical Center, Box 3800, Durham, NC 27710 (e-mail: patz0002@mc.duke.edu).

The first 10% of the full text of this article appears below.

The role of screening for lung cancer has been debated for more than 50 years. In 1949, the first lung cancer survey study including more than 530 000 persons living in Boston was initiated (1), and in 1951, the first prospective screening trial, known as the Philadelphia Pulmonary Neoplasm Research Project, began (2). After the National Cancer Act in 1971, there was renewed interest in lung cancer screening with chest radiographs and sputum cytology that gave rise to three large randomized trials in the United States, including the Mayo Lung Project (3–5).

When the data from the Mayo Lung Project were analyzed in the . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
E. F. Patz Jr, M. J. Campa, E. B. Gottlin, I. Kusmartseva, X. R. Guan, and J. E. Herndon II
Panel of Serum Biomarkers for the Diagnosis of Lung Cancer
J. Clin. Oncol., December 10, 2007; 25(35): 5578 - 5583.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Aisner
CT Screening for Lung Cancer: Are We Ready for Wide-Scale Application?
Clin. Cancer Res., September 1, 2007; 13(17): 4951 - 4953.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Dubey and C. A. Powell
Update in Lung Cancer 2006
Am. J. Respir. Crit. Care Med., May 1, 2007; 175(9): 868 - 874.
[Full Text] [PDF]

Home page
 JAMAHome page
A. I. Neugut and J. S. Jacobson
Women and lung cancer: gender equality at a crossroad?
JAMA, July 12, 2006; 296(2): 218 - 219.
[Full Text] [PDF]